News Image

Top movers in Tuesday's session

By Mill Chart

Last update: Apr 9, 2024

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Today's top gainers

TickerChangeComment
ALLR2.0K%Exciting news for ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) as its stock price surged 2.0K% to $4.46 during Tuesday's session. The stock is trading 46.37% lower than a month ago.
LASE100.0%LASER PHOTONICS CORP (NASDAQ:LASE) experienced a significant 100.0% increase, reaching $2.86 during Tuesday's session. A press release (Laser Photonics Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System) was released earlier today.
MGAM98.0%MOBILE GLOBAL ESPORTS INC's (NASDAQ:MGAM) shares rose 98.0% to $0.24. In the last month the share price dropped with 42.42%.
SLNA75.75%SELINA HOSPITALITY PLC (NASDAQ:SLNA) experienced a significant 75.75% increase, reaching $0.07 during Tuesday's session. In the last month the stock lost 84.13%.
MDIA59.9%MEDIACO HOLDING INC-CL A's (NASDAQ:MDIA) shares soared 59.9% to $4.83 during Tuesday's session. In the last month the share price increased with 491.0%.
CNXA44.95%Investors witnessed a remarkable 44.95% rise in CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) shares, which climbed to $0.58 during Tuesday's session. In the last month the share price increased with 68.08%.
GPAK33.39%GAMER PAKISTAN INC's (NASDAQ:GPAK) stock price is advancing with 33.39% to a price of $0.29. Shareholders saw the stock price going 35.16% lower in the past 3 months.
BSGM30.65%With a 30.65% surge, BIOSIG TECHNOLOGIES INC's (NASDAQ:BSGM) stock price reached $1.62 during Tuesday's session, signaling positive momentum. Shareholders saw the stock price going 100.0% higher in the past month.
SYRS28.44%SYROS PHARMACEUTICALS INC's (NASDAQ:SYRS) stock price increased by 28.44% to $5.78. A press release (Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression) was released earlier today.
IZM25.0%ICZOOM GROUP INC -CLASS A's (NASDAQ:IZM) shares rose 25.0% to $29.0 during Tuesday's session. The stock is trading 151.0% higher than a month ago.

For the full top gainers list go to our top gainers page.

Today's top losers

TickerChangeComment
VINC-74.47%VINCERX PHARMA INC's (NASDAQ:VINC) stock price encountered a 74.47% decline, reaching $1.22 during Tuesday's session. In the last month the share price dropped with 39.65%.
WAVE-33.33%Investors witnessed a 33.33% drop in ECO WAVE POWER GLOBAL AB-ADR's (NASDAQ:WAVE) stock price, which closed at $2.8 during Tuesday's session. In the last month the share price increased with 213.0%.
AZTR-21.67%Investors witnessed a 21.67% decrease in AZITRA INC's (NYSEARCA:AZTR) stock price, which closed at $0.17 during Tuesday's session. In the last 3 months the stock lost 81.5%.
HUBC-21.64%HUB CYBER SECURITY LTD's (NASDAQ:HUBC) stock price decreased by 21.64% to $1.05. Shareholders saw the stock price going 27.57% lower in the past 3 months.
WGSWW-20.21%GENEDX HOLDINGS CORP (NASDAQ:WGSWW) encountered a 20.21% decrease in its shares, reaching $0.03 during Tuesday's session. In the last month the stock lost 59.4%.
TLRY-19.88%The market experienced a downward movement in TILRAY BRANDS INC's (NASDAQ:TLRY) stock price, closing at $2.08 with a 19.88% decrease during Tuesday's session. The company's earnings where released Yesterday. Earlier today the company had a press release: Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results.
KA-19.24%KINETA INC's (NASDAQ:KA) shares fell 19.24% to $0.44 during Tuesday's session. Shareholders saw the stock price going 22.3% lower in the past month.
FCUV-17.91%Investors witnessed a 17.91% drop in FOCUS UNIVERSAL INC's (NASDAQ:FCUV) stock price, which closed at $0.29 during Tuesday's session. In the last 3 months the stock lost 76.69%.
CVKD-16.96%CADRENAL THERAPEUTICS INC (NASDAQ:CVKD) encountered a 16.96% decrease in its shares, reaching $0.42 during Tuesday's session. In the last month the stock lost 23.84%.
VVPR-16.25%The market experienced a 16.25% downturn in VIVOPOWER INTERNATIONAL PLC's (NASDAQ:VVPR) stock price, closing at $4.69 during Tuesday's session. A press release (VIVOPOWER ANNOUNCES FURTHER STRATEGIC DIRECT INVESTMENT IN TEMBO FROM EMIRATI INVESTMENT OFFICE) was released yesterday.

To see the full list of top losers you can use our top losers page.

Back

ALLARITY THERAPEUTICS INC

NASDAQ:ALLR (5/3/2024, 7:00:00 PM)

After market: 1.03 +0.03 (+3%)

1

-0.23 (-18.7%)

ALLR News

News Image2 days ago - ChartmillWhich stocks are experiencing notable movement on Friday?

Which stocks are experiencing notable movement on Friday?

News Image3 days ago - ChartmillThursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.

News Image3 days ago - InvestorPlaceJPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock

Carvana stock is climbing higher on Thursday after shares of CVNA got an increased price target and upgrade from JPMorgan analyst Rajat Gupta.

News Image3 days ago - InvestorPlaceEmergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts

Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities.

News Image3 days ago - InvestorPlaceWhy Is Allarity Therapeutics (ALLR) Stock Up 39% Today?

Allarity Therapeutics stock is rising higher on Thursday as investors in ALLR celebrate the company ending a clinical trial early.

News Image3 days ago - ChartmillGapping stocks in Thursday's session

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

News Image3 days ago - ChartmillThursday's pre-market session: top gainers and losers

Get insights into the top gainers and losers of Thursday's pre-market session.

News Image3 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
News Image3 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...

News Image6 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
News Image6 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...

News Image18 days ago - Allarity Therapeutics, Inc.Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
ALLR Links
Follow us for more